Target intelligence / Profile preview

Casein kinase I isoform delta (CSNK1D) (CSNK1D)

Target
CSNK1D
Molecular classification
Enzyme, Serine/threonine-protein kinase, Casein kinase 1 family
01

Overview

Casein kinase I isoform delta (CK1 delta) is a member of the highly conserved serine/threonine protein kinase family that plays a pivotal role in regulating the eukaryotic circadian clock (UniProt: P48730). It phosphorylates Period proteins (PER1, PER2, and PER3), marking them for ubiquitination and proteasomal degradation, which is essential for maintaining the ~24-hour rhythm (Toh et al., Science, 2001). Beyond chronobiology, CK1 delta is involved in diverse cellular processes including DNA damage repair, Wnt/beta-catenin signaling, and microtubule dynamics (Knippschild et al., Cell Signal, 2005). Dysregulation of this kinase is linked to various pathologies; for instance, mutations in the CSNK1D gene cause Familial Advanced Sleep Phase Syndrome (FASPS), while its overexpression is observed in several cancers, including breast, pancreatic, and colon cancer (Cheong & Virshup, J Biochem, 2011). In neurodegenerative diseases like Alzheimer's and ALS, CK1 delta is implicated in the pathological phosphorylation of tau and TDP-43 (Xu et al., Int J Mol Sci, 2019). Pharmacological targeting of CK1 delta focuses on small-molecule inhibitors that compete for the ATP-binding pocket, such as PF-670462, though achieving selectivity over the closely related CK1 epsilon isoform remains a significant therapeutic challenge (Janovska et al., Br J Pharmacol, 2020).

Other names
CK1 deltaCK1dCasein kinase 1 deltaHCKIDSerine/threonine-protein kinase Casein kinase I isoform delta
02

Mechanism of action

ATP-competitive inhibition of the kinase domain to prevent phosphorylation of downstream substrates such as PER proteins and p53 (Janovska et al., Br J Pharmacol, 2020).

03

Biological functions

Circadian rhythm regulationDNA repairCell cycle progressionWnt signalingCytoskeleton organizationApoptosisProtein phosphorylation
04

Disease associations

CancerNeurodegenerative diseaseSleep disorderAlzheimer's diseaseParkinson's diseaseFamilial advanced sleep phase syndrome
05

Safety considerations

Circadian rhythm disruptionIsoform selectivity (delta vs epsilon)Gastrointestinal toxicityOff-target kinase inhibition
06

Interacting drugs

PF-670462

4 more in the full profile.

07

Biomarkers

PER2 phosphorylation statusTDP-43 phosphorylation levelsTau phosphorylation status

Beyond the preview

Go deeper on Casein kinase I isoform delta (CSNK1D) (CSNK1D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Casein kinase I isoform delta (CSNK1D) (CSNK1D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call